BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Juno Therapeutics to Report Third Quarter 2017 Financial Results on Wednesday, November 1

  Juno Therapeutics, Inc. will announce financial results for the third quarter 2017 on Wednesday, November 1, 2017, after the close of U.S.-based financial markets.

  October 25, 2017

   · 

  4 min read
• Drug Development

  Anika Completes Enrollment in Second Pivotal Phase III Trial of CINGAL for the Treatment of Knee Pain Associated With Osteoarthritis

  Anika Therapeutics today announced the completion of enrollment in its second pivotal Phase III trial evaluating CINGAL, its novel HA-corticosteroid combination viscosupplement1 for the treatment of symptoms associated with osteoarthritis (“OA”) of the knee.

  October 25, 2017

   · 

  5 min read
• Business

  Innoviva Reports Third Quarter 2017 Financial Results and Provides Business Updates

  Innoviva reported financial results for the third quarter of 2017. Gross royalties earned on net sales of RELVAR/BREO ELLIPTA and ANORO ELLIPTA from Glaxo Group Limited (GSK) during the third quarter of 2017 were $51.9 million, up 42% from $36.5 million in the third quarter of 2016.

  October 25, 2017

   · 

  16 min read
• Business

  Anika Reports Third Quarter 2017 Financial Results

  Anika Therapeutics, Inc. reported financial results for the third quarter ended September 30, 2017, along with business progress in the period.

  October 25, 2017

   · 

  11 min read
• Lone Star Bio

  CoorsTek Medical Announces the First Human Implantation of a New, State-of-the-Art Sacroiliac Fusion System

  CoorsTek Medical announced the first human implantation of a new generation of MIS Sacroiliac fusion implants.

  October 25, 2017

   · 

  2 min read
• Deals

  Endo Completes Divestiture of Grupo Farmaceutico SOMAR

  Endo International today announced the completion of the previously announced sale of Grupo Farmaceutico SOMAR to Advent International for a purchase price of approximately $124M.

  October 25, 2017

   · 

  2 min read
• Business

  Vertex Reports Third-Quarter 2017 Financial Results

  Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the third quarter ended September 30, 2017.

  October 25, 2017

   · 

  30 min read
• Business

  TESARO to Announce Third-Quarter 2017 Financial Results on November 7, 2017

  This quarterly earnings call will be available via phone and webcast.

  October 25, 2017

   · 

  1 min read
• Drug Development

  Clearside Biomedical Announces Completion of Patient Enrollment in Phase II Clinical Trial of CLS-TA Used Together with Eylea in Patients with Diabetic Macular Edema

  The trial has enrolled 71 patients who are naïve to pharmacologic treatment for DME.

  October 25, 2017

   · 

  4 min read
• SYGNIS AG Announces the Launch of the Universal Lateral Flow Assay Kit and Associated Patent Filing

  SYGNIS AG today announced the launch of its Universal Lateral Flow Assay (LFA) kit, the latest addition to its expanding range of lateral flow assay products and services which are being commercialized under the Innova Biosciences brand name.

  October 25, 2017

   · 

  3 min read